Federal contract award
36C26124N0090
PLUVICTO PROSTATE CANCER TREATMENT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 261-NETWORK CONTRACT OFFICE 21 (36C261) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79719D0169 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.8M |
| Current contract value | $1.8M |
| Potential contract value / ceiling | $1.8M |
| Start date | Oct 1, 2023 |
| Current end date | Sep 30, 2024 |
| Potential end date | Sep 30, 2024 |
| Latest award activity | May 1, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 1, 2026 | P00003 | $-292.2K | DEOBLIGATE AND CLOSEOUT FY24 FUNDS, PO# 640C49015, FLUVICTO - LUTETIUM |
| May 15, 2025 | P00002 | $-810.3K | DEOBLIGATE EXCESS FUNDS AND CLOSE |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.